Literature DB >> 31674167

Response to Comment on "Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis".

Jung-Soo Pyo1, Nae Yu Kim2, Won Jin Cho3.   

Abstract

Entities:  

Year:  2019        PMID: 31674167      PMCID: PMC6877444          DOI: 10.4132/jptm.2019.09.27

Source DB:  PubMed          Journal:  J Pathol Transl Med        ISSN: 2383-7837


× No keyword cloud information.
This study aimed to elucidate the prognostic roles of claudin-1 immunohistochemistry in various malignant tumors through a meta-analysis. Data from all included studies were extracted by two independent authors (J.S.P. and N.Y.K.). Any disagreements for extracting data were resolved by consensus. In the present study, to review more articles, we used the narrow exclusion criteria. Therefore, discordance for the literature collection did not occur. We assessed the risk of bias for all included studies according to the Newcastle-Ottawa Scale. The detailed information was shown in Table 1. All data for survivals were a 5-year survival rate. If the extractable data only included the survival curve, survival rates at 5-year were obtained from the survival curve.
Table 1.

The Newcastle-Ottawa Scale for the quality assessment of eligible studies

StudySelection
Comparability
Outcome
Score
Representativeness of the exposed cohortSelection of the non-exposed cohortAscertainment of exposureDemonstration that outcome of interest was not present at start of studyComparability of cohorts on the basis of the design or analysisAssessment of outcomeWas follow-up long enough for outcomes to occurAdequacy of follow-up of cohorts
Ma et al. (2014) [1]NANANA*****5
Morohashi et al. (2007) [2]NANANA*****5
Matsuoka et al. (2011) [3]NANANA*****5
Resnick et al. (2005) [4]NANANA****4
Shibutani et al. (2013) [5]NANANA*****5
Yoshida et al. (2011) [6]NANANA*****5
Miyamoto et al. (2008) [7]NANANA*****5
Xiong et al. (2011) [8]NANANA*****5
Li et al. (2015) [9]NANANA*****5
Sappayatosok and Phattarataratip (2015) [10]NANANA*****5
Fritzsche et al. (2008) [11]NANANA*****5
Shin et al. (2011) [12]NANANA*****5
Bouchagier et al. (2014) [13]NANANA*****5
Higashi et al. (2007) [14]NANANA*-***4
Chae et al. (2014) [15]NANANA*-***4
Chao et al. (2009) [16]NANANA*-***4
Merikallio et al. (2011) [17]NANANA*****5
Zhang et al. (2013) [18]NANANA*****5
Huang et al. (2014) [19]NANANA*****5
Jung et al. (2011) [20]NANANA*****5
Tzelepi et al. (2008) [21]NANANA*****5
Hoellen et al. (2017) [22]NANANA*****5

NA, not available; *, criteria satisfied; –, criteria not satisfied.

  22 in total

1.  Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma.

Authors:  Yukihiro Higashi; Shohachi Suzuki; Takanori Sakaguchi; Toshio Nakamura; Satoshi Baba; Hans-Christian Reinecker; Satoshi Nakamura; Hiroyuki Konno
Journal:  J Surg Res       Date:  2007-01-30       Impact factor: 2.192

2.  Claudin-1 expression in cervical cancer.

Authors:  Friederike Hoellen; Annika Waldmann; Constanze Banz-Jansen; Uwe Holtrich; Thomas Karn; Martina Oberländer; Jens K Habermann; Mareike Hörmann; Frank Köster; Julika Ribbat-Idel; Marc Thill; Achim Rody; Ahmed El-Balat; Lars Hanker
Journal:  Mol Clin Oncol       Date:  2017-08-25

3.  Expression of claudin-1 and its relationship with lymphatic microvessel generation in hypopharyngeal squamous cell carcinoma.

Authors:  W J Li; Z L Zhang; X M Yu; X L Cai; X L Pan; X Y Yang
Journal:  Genet Mol Res       Date:  2015-10-02

4.  Expressions of cell junction regulatory proteins and their association with clinicopathologic parameters in benign and malignant gallbladder lesions.

Authors:  Li Xiong; Yu Wen; Xiongying Miao; Zhulin Yang
Journal:  Am J Med Sci       Date:  2011-11       Impact factor: 2.378

5.  Cluster analysis of claudin-1 and -4, E-cadherin, and β-catenin expression in colorectal cancers.

Authors:  Takashi Matsuoka; Hiroyuki Mitomi; Naoshi Fukui; Hideki Kanazawa; Tsuyoshi Saito; Takuo Hayashi; Takashi Yao
Journal:  J Surg Oncol       Date:  2011-02-24       Impact factor: 3.454

6.  Expression of claudin-1 and -7 in clear cell renal cell carcinoma and its clinical significance.

Authors:  Hong Il Shin; Byung Hoon Kim; Hyuk Soo Chang; Chun Il Kim; Hye Ra Jung; Choal Hee Park
Journal:  Korean J Urol       Date:  2011-05-24

7.  The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue.

Authors:  Hun Jung; Kyong Hwa Jun; Ji Han Jung; Hyung Min Chin; Woo Bae Park
Journal:  J Surg Res       Date:  2010-03-06       Impact factor: 2.192

8.  Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.

Authors:  Florian R Fritzsche; Beibei Oelrich; Manfred Johannsen; Ilka Kristiansen; Holger Moch; Klaus Jung; Glen Kristiansen
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

9.  Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma.

Authors:  Kraisorn Sappayatosok; Ekarat Phattarataratip
Journal:  Head Neck Pathol       Date:  2014-07-31

10.  Prognostic significance of claudin 4 in completely resected adenocarcinoma of the lung.

Authors:  Min Cheol Chae; Chang Kwon Park; Dong Yoon Keum; Ilseon Hwang; Kun Young Kwon; Byeong Churl Jang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-06-05
View more
  1 in total

1.  The Significance of Relative Claudin Expression in Odontogenic Tumors.

Authors:  Ekarat Phattarataratip; Kraisorn Sappayatosok
Journal:  Head Neck Pathol       Date:  2019-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.